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Abstract
Background: Oxidative stress and matrix metalloproteinases -9 and -2 are involved in periodontal breakdown,
whereas gingival crevicular fluid has been reported to reflect apical status. The aim of this study was to
characterize oxidant balance and activity levels of MMP -2 and -9 in apical lesions and healthy periodontal
ligament; and second, to determine whether potential changes in oxidant balance were reflected in gingival
crevicular fluid from asymptomatic apical periodontitis (AAP)-affected teeth at baseline and after endodontic
treatment.
Methods: Patients with clinical diagnosis of AAP and healthy volunteers having indication of tooth extraction were
recruited. Apical lesions and healthy periodontal ligaments, respectively, were homogenized or processed to obtain
histological tissue sections. Matrix metalloproteinase -9 and -2 levels and/or activity were analyzed by
Immunowestern blot, zymography and consecutive densitometric analysis, and their tissue localization was
confirmed by immunohistochemistry. A second group of patients with AAP and indication of endodontic
treatment was recruited. Gingival crevicular fluid was extracted from AAP-affected teeth at baseline, after
endodontic treatment and healthy contralateral teeth. Total oxidant and antioxidant status were determined in
homogenized tissue and GCF samples. Statistical analysis was performed using STATA v10 software with unpaired t
test, Mann-Whitney test and Spearman’s correlation.
Results: Activity of MMP-2 and MMP-9 along with oxidant status were higher in apical lesions (p < 0.05). Total
oxidant status correlated positively with matrix metalloproteinase-2 and lesion size (p < 0.05). Gingival crevicular
fluid showed significantly lower levels of total antioxidant status in diseased teeth at baseline compared to controls
and endodontically-treated groups.
Conclusions: Apical lesions display an oxidant imbalance along with increased activity of matrix metalloproteinase-
2 and -9 and might contribute to AAP progression. Oxidant imbalance can also be reflected in GCF from AAP-
affected teeth and was restored to normal levels after conservative endodontic treatment. These mediators might
be useful as potential biomarkers for chair-side complementary diagnostic of apical status in GCF.
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Asymptomatic apical periodontitis (AAP) corresponds to
the inflammation and destruction of periradicular tissues
caused by bacterial infection of dental pulp. It is the
most common consequence of untreated dental caries
and leads frequently to tooth loss. The hallmark of AAP
is the presence of an apical lesion (AL) that results from
destruction of hard and soft apical tissues [1,2].
The generation of reactive oxygen species (ROS),
namely superoxide, hydroxyl and nitric oxide radicals,
hydrogen peroxide and hypochlorous acid, represents an
important pathogenic mechanism for diseases associated
with phagocytic infiltration and bone resorption [3,4] as
a host defense mechanisms against the invading patho-
gen [5]. Accordingly, neutrophils obtained from periph-
eral blood of AAP subjects have shown increased
production of hydrogen peroxide and superoxide anion,
which tend to normalize after surgical treatment [6,7].
Nevertheless, oxidant status in apical tissues remains
unknown. As oxidant effects are additive, measuring the
total oxidant (TOS) and antioxidant status (TAS) of a
sample can provide a new and practical approach [8,9].
Matrix metalloproteinases (MMPs) are zinc and cal-
cium-dependent endopeptidases that function at neutral
pH. Fibrillar collagens are the major components of peri-
odontal extracellular matrix. During periodontal homeos-
tasis and pathologic conditions, they are cleaved into
smaller fragments by collagenases (MMPs -1, -8, and -13)
and further degraded by active gelatinases (MMPs -2 and
-9) and other non specific tissue proteinases [10]. MMP-
9 and MMP-2 have been identified through immunohis-
tochemistry in experimentally-induced apical periodonti-
tis in animal models where they were proposed to play a
role in both, the initiation and progression of apical peri-
odontitis [11,12]. Previous works have demonstrated
increased mRNA expression levels of MMP-9 in apical
granulomas in comparison to cysts [13,14], as well as
MMP-9 activity levels in apical exudates from acute ver-
sus apical abscesses [15]. Furthermore, recent preliminary
studies reported for the first time that gingival crevicular
fluid (GCF) composition changes in AAP-affected teeth,
showing increments in MMP-9 activity, frequency of
detection of MMP-2 and total protein content in com-
parison to healthy controls [16,17]. Despite gelatinase
activity has been reported in oral fluids during AAP, no
previous determination of MMP-9 and -2 activities has
been performed in apical lesions to support that these
findings actually reflect apical status. Study of GCF parti-
cularly represents a novel approach in the search of bio-
markers for apical periodontitis. In order to further
understand whether changes in GCF reflect apical status,
these changes should be demonstrated in both, apical
lesions and GCF.
Additionally, new evidence of an oxidative regulation
of MMP expression and activity in chronic periodontitis
is emerging [18], but this association has never been
reported in AAP, despite both diseases share common
pathogenic mechanisms. Consequently, it is proposed
that apical lesions present higher MMP-2 and MMP-9
activity compared to healthy PDL in association with
oxidant status and that these changes can be reflected in
GCF.
The aim of this study was first, to characterize and
associate oxidant balance and the activity levels of MMP
-2 and -9 in apical lesions and healthy periodontal liga-
ment; and second, to determine whether potential
changes in oxidant balance were reflected in GCF from
AAP-affected teeth.
Materials and methods
Design: Analytic longitudinal study
Study subjects
Patients consulting at the clinics of diagnosis and endo-
dontics, School of Dentistry, University of Chile were
enrolled if they had clinical diagnosis of asymptomatic
apical periodontitis (AAP) as previously described [19].
Diagnostic criteria included the presence of one or more
apical lesions (compatible with an apical granuloma or
cyst) detected by apical radiography (> 3 mm diameter)
due to dental caries in teeth with clinical determination
of non-vital pulp. The size of the radiographic apical
lesion was registered as the average of vertical and hori-
zontal diameters.
The teeth were selected if they had indication of tooth
extraction or endodontic treatment. Exclusion criteria
included marginal periodontal diseases defined by the
absence of clinical attachment loss (≤ 2 mm), increased
probing depths (≤ 3 mm) and bleeding on probing in less
than 10% of the probing sites at examination; current
smokers, systemic illness or previous antibiotics or non-
steroid anti-inflammatory treatment during the 6-month
period prior to the study. Healthy periodontal ligaments
were also obtained from teeth with indication of extrac-
tion for orthodontic reasons from healthy donors as con-
trols. All the protocols and procedures were approved by
the Ethics Committee guidelines from University of Chile
and in accordance with the ethical standards of the
Declaration of Helsinki. The informed consent was
obtained from all individuals. A minimal sample size of
10 patients in each group was determined with 90%
power and a significance level of 5%.
Tissue samples
Apical lesions (AL) and healthy periodontal ligaments
(PDL) were obtained from AAP and healthy subjects
with indication of teeth extraction for subsequent tissue
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group of tissue samples were fixed in buffered formalde-
hyde at 4% and included in paraffin for routine proces-
sing, diagnosis of apical granuloma (n = 4) or healthy
periodontal ligament (n = 4), and immunohistochemis-
try (Figure 1). Mean age for apical periodontitis group
was 50.1 ± 17.5 years old and 23.2 ± 3.8 years old for
control group. Among them, 5 and 8 corresponded to
females in each group, respectively.
Tissue samples for homogenization procedures were
weighted and protein extracts were prepared by an auto-
mated homogenizer in 50 mM Tris-HCl pH 7.5, 0.2 M
NaCl, 5 mM CaCl2 and 0.01%Triton X-100 buffer adding
EDTA-free proteinase inhibitor cocktail (Roche Diagnos-
tics GmbH) in a constant ratio of 10 μL of buffer per mg
of weighted tissue, centrifuged at 13000 × g for 6 min. at
4°C; the pellet was resuspended in the same buffer and
kept under -80° until further analysis.
Gingival crevicular fluid samples
GCF samples were obtained from patients having indi-
cation of conservative endodontic treatment from
around affected teeth (N = 16) at baseline, one week
after completion of the endodontic treatment, and from
controls corresponding to healthy contra lateral tooth in
each subject (Figure 1). The mean age was 39.5 years
old and 12 corresponded to females.
After isolating the tooth with a cotton roll, the crevicu-
lar site was gently dried with an air syringe. GCF was col-
lected with standard commercial paper strips (ProFlow,
Amityville, New York, USA). Strips were placed into the
Figure 1 Schematic representation of sample types and their respective analyses. AAP: Asymptomatic apical periodontitis; TOS: Total
oxidant status; TAS: Total antioxidant status AL: Apical lesions; HPL: Healthy periodontal ligament; IHC: Immunohistochemistry; IWB:
Immunowestern blot;.
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for 30s. Strips contaminated by saliva or blood were
excluded.
After GCF collection, strips were placed in microtubes
and kept at -20°C. GCF was extracted by centrifugation
at 9000 × g for 6 min in a final volume of 5 μLo fe l u t i o n
buffer containing 50 mM Tris-HCl pH 7.5, 0.2 M NaCl, 5
mM CaCl2 and 0.01%Triton X-100, adding EDTA-free
proteinase inhibitor cocktail (Roche Diagnostics GmbH)
and samples were stored at -20°C until further analysis.
Sample analysis
Immunohistochemistry
To confirm tissue localization of MMPs -2 and -9, tissue
sections of 6 micrometers were cut, deparaffinized and
endogenous peroxidase activity was quenched by incuba-
tion in 10% hydrogen peroxide. Antigen retrieval was done
with Proteinase K following manufacturer’s recommenda-
tions (Novocastra
®, Lab. Novo, Newcastle, UK) and unspe-
cific blocking was performed with 2.5% horse serum for 10
min. (Kit ABC Universal, RTU Vectastain
® Kit for labora-
tory use, Burlingame, CA, USA.). Respective monoclonal
primary antibodies against human MMP-2 or MMP-9
(R&D Systems, Inc
®, Minneapolis, MN, USA), were incu-
bated overnight in 1:20 and 1:10 dilutions, respectively and
rinsed. The immunostainings were performed with Vectas-
tatin Elite ABC kit (Vector Laboratories, Burlingame, CA),
using anti-mouse biotinylated secondary antibody, revealed
with DAB (Peroxidase Sustrate Kit, Zymed Labs INC
®,S a n
Francisco, CA, USA), counterstained with Mayer’s hema-
toxylin (Merck KGaA, Darmstadt, Germany) and mounted.
Slides were examined using an optical microscope (Zeiss,
Axiostar Plus
®, NY, USA) and representative images were
acquired using a digital camera (Canon, Powershot A640,
Tokyo, Japan). Positive and negative controls were pro-
cessed with each series.
Gelatin zymography
Gelatinase activity was assessed in tissue homogenates.
Aliquots were run under non-reducing denaturing condi-
tions in 10% SDS/PAGE gels containing 1 mg/mL gelatin
as substrate, soaked twice in 2.5% Triton X-100 and incu-
bated in developing buffer (20 mM Tris pH 7.4 and 5 mM
CaCl2) during 17 h, stained with Coomassie Brilliant Blue
R-250 and destained with 10% acetic acid and 20% metha-
nol solution. To measure gelatinolytic activities, densito-
metric analysis was performed using UNSCAN-IT gel
automated digitizing system V4.1 software (Silk Scientific
Corporation, Orem, UT, USA) and results were expressed
as arbitrary densitometric units/mg of tissue (au/mg).
Identification of MMP-2 and MMP-9 by
immunoimmunowestern blots
To identify MMP-2 and MMP-9 immunoreactivities and
confirm the identity of gelatinolytic bands, aliquots of tis-
sue homogenates were run under reducing conditions
into 10% SDS/PAGE gels and transferred to nitrocellu-
lose membranes. The membrane was blocked with 3%
skim milk in Tris Buffered Saline - Tween 0.1% (TBS-T)
for 1 hour. Primary monoclonal antibodies against
MMP-2 and MMP-9 (R&D Systems, USA) in 1:200 and
1:100 dilutions respectively were added and the mem-
brane was incubated overnight. The membrane was
washed with TBS-T, incubated for 1 hour with HRP-con-
jugated secondary antibody, washed again and detection
was performed with an enhanced chemiluminiscence
(ECL) detection kit (Femto, Pierce, Rockford, USA).
Total Oxidant Status (TOS)
TOS levels in tissue homogenates and GCF eluates were
determined by the measurement method previously
described [8]. The assay was calibrated with hydrogen
peroxide (H2O2). Briefly, 225 μl Reagent 1 (150 μMx y l e -
nol orange, 140 mM NaCl and 1.35 M glycerol in 25 mM
H2SO4 solution, pH 1.75) was mixed with 35 μl of each
r e s p e c t i v es a m p l ea n dt h ea b s o r b a n c ea t5 6 0n mw a s
read with a spectrophotometer as each sample blank.
Then, 11 μlR e a g e n t2( 5m Mf e r r o u si o na n d1 0m Mo -
dianisidine in 25 mM H2SO4 solution) was added and the
absorbance was read again at 560 nm after 3 min. The
results were expressed as μmol H2O2 equiv/L. per mg of
tissue homogenates and per 30 s. of GCF sampling.
Total Antioxidant status (TAS)
Tissue homogenates and GCF eluates were measured by a
Total Antioxidant Status commercial kit (Randox Labora-
tories, Ardmore, UK) as previously performed [20]. Briefly,
metmyoglobin is turned into ferrymyoglobin in the pre-
sence of iron. Addition of Randox reagent di-(3-ethyl-
benzthiazoline sulphonate) (ATBS
®)r e s u l t si nt h e
formation of a blue-green coloured radical that could be
detected at 630 nm. The inhibition of radical formation by
the antioxidants from the sample was calculated in mM
quantities of ATBS
® disappearance and expressed per mg
of tissue for homogenates and per 30 s. of GCF sampling.
Statistical analysis
Statistical analysis was performed using STATA v10
software (StataCorp, Collage Station, TX, USA). MMPs,
TOS and TAS comparisons between AL and control tis-
sue groups were analyzed by unpaired t test and Mann-
Whitney test, depending whether data distribution was
normal or not and Spearman’s correlation. TOS and
TAS comparisons in GCF between AAP versus contral-
ateral control teeth and baseline versus post-treatment
determinations were performed using paired-t test. Sta-
tistical significance was considered if p < 0.05.
Results
Apical lesions and healthy periodontal ligament
MMP-9 and MMP-2 enzymatic forms were detected by
gelatin zymography in all tissue homogenates from apical
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Immunoreactivities for MMP-9 and MMP-2 proenzyme
and active forms were confirmed by Immunowestern blot
(Figure 2B). Significantly higher gelatinolytic activity corre-
sponding to active enzyme and proforms of MMP-9 were
found in apical lesions compared to healthy PDL (p =
0.0004 and p = 0.001, respectively). Similarly, MMP-2
bands corresponding to active and proenzyme forms were
significantly higher in diseased group (p = 0.018 and p =
0.009, respectively) (Figure 3).
Immunopositive cells for MMP-9 and MMP-2 in api-
cal granulomas were mainly localized to inflammatory
infiltrates (Figure 4, A-D). MMP-9 immunopositive cells
were identified according to cell morphology as neutro-
phils (PMNs) and mononuclear cells (Figure 4B). Simi-
larly, MMP-2 was immunolocalized to mononuclear
cells (Figure 4D).
TOS and TAS were higher in apical lesions compared
to healthy periodontal ligament, but differences were
significant only for TOS (p = 0.006 and p = 0.06,
respectively; Table 1).
Correlation analysis of all tissue homogenates demon-
strated that TOS correlated positively with active MMP-2
(r = 0.58, p = 0.008). Active MMP-2 also correlated with
proMMP-9 (r = 0.6, p = 0.005), as well as active MMP-9
(r = 0.45, p = 0.047), but the later was borderline signifi-
cant. When the aforementioned associations were ana-
lyzed separately (Table 2), TOS and active MMP-2 still
displayed a tendency to a positive correlation (r = 0.7,
p = 0.058) in apical lesions, whereas TOS and TAS were
inversely correlated (r = -0.8, p = 0.009). TOS also corre-
lated positively with apical lesion size (r = 0.6, p = 0.02).
No correlations for TOS were found in healthy PDL
group.
Because the mean age varied considerably among
donors of apical tissue samples (apical lesions and
healthy PDL), the existence of a potential association
between age and the levels of the studied mediators was
assessed by Spearman’s correlation. No association was
found between TOS, MMP-9 or MMP-2 and age (p >
0.05); whereas TAS and age displayed a positive correla-
tion of borderline significance in the diseased group (r =
0.68, p = 0.044).
GCF
Analysis of TOS and TAS levels in GCF from AAP sub-
jects (Table 1) demonstrated no differences in TOS levels
between AAP and respective contralateral control samples,
as well as AAP at baseline and after conservative endodon-
tic treatment (p > 0.05). TAS on the other hand, was
found to be significantly lower in AAP samples in compar-
ison to controls (p = 0.03). TAS levels after treatment
increased significantly compared to baseline, reaching
levels similar to control samples (p = 0.02).
Discussion
Periapical lesions result from the dynamic encounter
between microbial factors and host immune response in
subjects with clinical diagnosis of asymptomatic apical
periodontitis. Both, granulomas and radicular cysts, are
considered to represent two different stages of develop-
ment of the same inflammatory process and are charac-
terized by leukocyte infiltration. These cells represent
important regulators of extracellular matrix turnover and
destruction, representing the major source of bone-
resorbing mediators, including reactive oxygen species
and MMPs [5,6,16].
The results of the current study support that an oxi-
dative imbalance along with increments in MMP-9 and
MMP-2 levels and activity might play a role in the
development and/or progression of apical lesions.
Furthermore, oxidative imbalance at the expense of
Figure 2 MMP-9 and MMP-2 enzymatic forms in apical lesions and healthy periodontal ligament. Representative MMP-9 and MMP-2
enzymatic forms identified by gelatin zymography. B. MMP-9 and MMP-2 enzymatic forms identified by immunowestern blot. SMW: Standard of
molecular weight (kD); AL: Apical lesions; PDL: Healthy periodontal ligament; proMMP-9 and proMMP-2: Proenzyme forms; aMMP-9 and aMMP-2:
Active enzyme forms.
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AAP teeth, in comparison to healthy controls and endo-
dontically treated teeth.
Leukocytes and resident fibroblasts from periodontal
tissues are known to secrete MMPs, including MMPs
-1, -2, -3, -8, -9 and -13 [21-24]. During the last few
years, MMPs -2 and -9 have shown to be over expressed
at the mRNA level in apical granulomas [14,15] and
higher activity levels have been reported in apical exu-
dates from acute apical abscesses, as well as in GCF
from teeth affected with asymptomatic apical periodon-
titis versus healthy teeth [16]. The results of the current
study complement the previous findings reported in
GCF, showing significantly higher activity levels of both,
proenzymes and active forms of MMP-9 and MMP-2 in
apical lesions when compared to healthy periodontal
Figure 3 Activity levels of MMP-9 (A) and MMP-2 (B) in apical lesions and healthy periodontal ligament. PDL: Healthy periodontal
ligament; proMMP-9 and proMMP-2: proenzyme forms; aMMP-9 and aMMP-2: Active enzyme forms. *p < 0.05.
Figure 4 Immunolocalization of MMP-9 and MMP-2 in apical granulomas.A - B :M M P - 9 ;C - D :M M P - 2 ;M :M o n o n u c l e a ri n f l a m m a t o r yc e l l s ;
PMN: Neutrophils.
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and MMP-2 was confirmed in apical granulomas by
imunohistochemistry [13]. The study of GCF as a source
of potential biomarkers for AAP represents a novel
approach that needs further validation. Overall, these
data support that changes in MMP activity in GCF are
similar as those for apical lesions.
Previous works support that MMP -2, MMP-9 and
MMP-13 play important roles in both, the initiation and
progression of inflammatory bone resorption and soft
periodontal tissue breakdown during pathological pro-
cesses, including chronic periodontitis [21,25-27]. Under
inflammatory conditions, bone resorptive mediators, like
interleukin-1 and prostaglandin E2, induce a marked
expression of RANKL and MMPs, such as MMP-13, -3
and -2 by osteoblasts and MMP-9 by activated osteo-
clasts and leukocytes [1,28]. Additionally, MMP-9 activity
is thought to act over preosteoclast recruitment and
migration [29].
High levels of oxidants in tissues perturb the normal
redox balance and shift cells into a state of oxidative stress
[30-32]. In the current study, we evidenced an oxidant
imbalance in favor to ROS in both, apical lesions and GCF
from AAP teeth versus healthy controls and endodonti-
cally-treated teeth. Evidence has led ROS to become
increasingly implicated in the damage of extracellular
matrix components from connective tissue incurred during
inflammatory diseases [33]. At the cellular level, ROS acti-
vate redox-sensitive transcription factors, including NF-B
and AP-1, thereby causing indirect tissue damage and
exacerbation of inflammation [9]. A positive correlation
between TOS and the bone resorptive area and a negative
correlation between TOS and TAS was found in apical
lesions, but not in healthy PDL. An imbalance in favor to
ROS might stimulate apical bone loss. Recent evidence has
shown that ROS might play an osteolytic role by suppres-
sing bone formation through inhibition of osteoblastic dif-
ferentiation, and by stimulating osteoclast differentiation
and bone resorption [34] through induction of receptor
activator of NFB ligand (RANKL). Additionally, higher
MMP-2 expression and activation in response to ROS has
been reported [3,35,36], evidencing a key link between
ROS production, MMP-mediated proteolysis and bone
resorption, which could play a central role in the progres-
sion of apical lesions. In line with these findings, an asso-
ciation between TOS and active MMP-2 was found in the
current study, suggesting that pro-oxidant status and
MMP-mediated proteolysis might be cooperative in nature
during AAP progression. In support of this, an association
between active MMP-8 and myeloperoxidase has recently
been reported during chronic periodontitis progression
[18].
Additionally, based on the fact that MMP-9 can induce
proMMP-2 activation in vitro [37,38], the finding of a
positive correlation between active MMP-9 and active
MMP-2 suggests that this activation mechanism might
also occur in vivo. A limitation of this study was the age
difference found between AAP groups and their respec-
tive controls. Healthy erupted teeth are obtained for
orthodontic purposes mostly in young patients. Never-
theless, a lack of association between age, TOS and
MMPs supports that the differences found resulted from
Table 1 TOS and TAS levels in tissue samples and GCF from asymptomatic apical periodontitis and controls.
AAP Controls p AAP BL AAP AT p
Tissue TOS (μmol H2O2 equiv) 29.33 ± 3.52 25.60 ± 2.74 0.006 ———
Tissue TAS (mM) 1.36 (0.85) 0.42 (2.19) 0.06 —— — —
GCF TOS (μmol H2O2 equiv) 2.44 ± 1.38 2.50 ± 2.33 0.46 2.81 ± 2.02 3.02 ± 2.17 0.39
GCF TAS (mM) 0.93 ± 0.68 1.34 ± 0.75 0.03 0.74 ± 0.62 1.20 ± 0.80 0.02
Values expressed as means ± standard deviation or medians (interquartile range). AAP: Asymptomatic apical periodontitis; BL: baseline; AT: after treatment.
Table 2 Spearman’s correlation matrix between MMPs and oxidative balance in apical lesions and healthy periodontal
ligament.
proMMP-9 aMMP-9 proMMP-2 aMMP-2 TOS TAS
AL PDL AL PDL AL PDL AL PDL AL PDL AL PDL
proMMP-9 1 1 —— — — —— — — ——
aMMP-9 -0.3 -0.2 1 1 — — —— — — ——
proMMP-2 0.2 0.6 0.1 -0.4 1 1 —— — — ——
aMMP-2 0.28 0.4 0.3 -0.2 0.4 0.3 1 1 —— — —
TOS 0.3 -0.6 -0.3 0.4 0.6 -0.4 0.7 0.03 1 1 ——
TAS -0.01 -0.3 0.1 -0.6 -0.6 0.2 -0.6 0.17 -0.8* 0.05 1 1
Lesion size 0.03 — 0.38 — 0.4 — 0.7 — 0.6
# — -0.6 —
AL: apical lesions, n = 9; PDL periodontal ligament, n = 11. Each box shows respective rho. Bolds show significant correlations; *p = 0.009; #p = 0.02.
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mechanisms involved in destruction of apical periodon-
tium will contribute to the development of improved
methods of diagnosis, treatment and follow-up for side-
diagnostic tools.
GCF represents a simple, non-invasive and useful tool
in monitoring inflammation and treatment response in
marginal periodontal diseases [39,40], but it has rarely
been studied in apical periodontitis. MMP activity or
active forms in GCF, particularly of MMP–13, MMP-9
a n dM M P - 8 ,h a v ep r e v i o u s l yb e e na s s o c i a t e dw i t hp r o -
gression and/or severity of marginal chronic periodonti-
tis [26,41]. Recently, changes in GCF composition,
involving higher gelatinase activity [16] and protein con-
centration, were reported in AAP in comparison to
healthy controls [17]. These studies provide preliminary
evidence supporting that GCF might reflect the health
status of the apical tissues, as well as apical disease pro-
gression. In line with these reports, the present study
shows the occurrence of an oxidant imbalance in apical
lesions and also in GCF from AAP teeth, whereas endo-
dontic treatment appears to restore antioxidant status to
its normal levels. Considering that treatment outcome is
difficult to predict based solely upon clinical and radio-
graphic criteria and classical samples for endodontic
purposes are invasive, GCF measurement of gelatinase
activities along with the oxidant balance might represent
a useful side- diagnostic tool, but further studies are
needed to confirm whether GCF can reflect apical
inflammation, its resolution and apical healing.
Conclusions
Inflammatory apical lesions were characterized by pro-
oxidant status and elevated MMPs -2 and -9 activity,
supporting their involvement in the pathogenesis of api-
cal periodontitis. Oxidant imbalance was also reflected
in GCF from affected teeth and was restored after con-
servative endodontic treatment. These mediators might
be useful as potential biomarkers for chair-side comple-
mentary diagnostic of apical status in GCF.
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